Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 23. Januar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8770  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 175386  
   
Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.
Prostate
Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, Fujimoto K, Tanaka N.
PMID: 41570179 [PubMed - as supplied by publisher]


Pelvic Lymph Node Staging With PSMA PET in Prostate Cancer: Surgical Validation With Implications for Radiotherapy Planning.
Prostate
Ozen A, Sarikaya Z, Gur C, Ozboru D, Canat HL.
PMID: 41570172 [PubMed - as supplied by publisher]


Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3 + 3 Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Study.
Prostate
Li H, Xiong S, Wang M, Liu M, Wang J, Wang J, Lv Z.
PMID: 41570160 [PubMed - as supplied by publisher]


First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinoma.
Cancer Chemother Pharmacol
Karaman I, Erdem D, Cetin B.
PMID: 41569310 [PubMed - indexed for MEDLINE]


NF-κB (p65, p50), IL-18, and IL-10 as Therapeutic Targets in Prostate Cancer and BPH: Molecular Insights into Inflammation-Driven Pathogenesis.
Asian Pac J Cancer Prev
Dwivedi S, Saini S, - A, Np AK, Bansal A, Sharma RS, Shekhar S, - D, Goel A, Khattri S.
PMID: 41569207 [PubMed - indexed for MEDLINE]


The Radical Prostatectomy Versus Brachytherapy for the Management of Low- and Intermediate-Risk Prostate Cancer: A Meta-Analysis of Observational Studies Focusing on Oncological Outcomes.
Asian Pac J Cancer Prev
Warli SM, Ikram MF, Kadar DD, Siregar GP, Prapiska FF, Laksmi LI, Tala ZZ, Siregar DI, Siregar MIS.
PMID: 41569192 [PubMed - indexed for MEDLINE]


Tumor Morphology as a Risk Factor for Muscle Invasiveness in Newly Diagnosed Bladder Cancer: A Stratified Analysis.
Asian Pac J Cancer Prev
Do NT, Nguyen Tung L, Nguyen Cong D, Do MT.
PMID: 41569182 [PubMed - indexed for MEDLINE]


First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study.
J Physiol Pharmacol
Strojny Z, Kanikowska A, Sikora W, Lewandowska M, Sato M, Strojny M, Zuraszek-Szymanska J, Deja T, Paszynska E, Korybalska K, Breborowicz A, Witowski J, Kanikowska D.
PMID: 41569057 [PubMed - indexed for MEDLINE]


Coriandrum sativum improves prognosis in clear cell renal cell carcinoma by targeting NEK6 to modulate the immune microenvironment: a predictive study based on network pharmacology and multi-omics analysis.
Artif Cells Nanomed Biotechnol
Li J, Zhang Y, Wang X, Zhang P, Xu Z, Huang R, Hu H.
PMID: 41568676 [PubMed - indexed for MEDLINE]


Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer.
Comb Chem High Throughput Screen
Chen DN, Wu XH, You Q, Zhuang RB, Ruan ZT, Zhu JM, Zheng QS, Chen YH, Wei Y, Lin XD, Xue XY.
PMID: 41568495 [PubMed - as supplied by publisher]


Overall Survival in Men 80 and Older With Intermediate-Risk Prostate Cancer Who are Treated With Dose-Escalated Radiation and Androgen Deprivation Therapy Versus Dose-Escalated Radiation Alone: A National Cancer Database Analysis.
Adv Radiat Oncol
Dougherty TP, Deng M, Hayes S.
PMID: 41568317 [PubMed]


Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study.
Front Immunol
He S, Wang C, Li X, Li C, Li D, Zhang B, Wan J, Yue Z, Wu G, Zhang S, Ma J, Shang P.
PMID: 41567212 [PubMed - indexed for MEDLINE]


Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.
BMC Cancer
Liu W, Kong W, Jiang S, Wei Y, Yu Z, Cao X, Yang J, Wei X, Shen L, Qin C, Zhu Q.
PMID: 41566241 [PubMed - indexed for MEDLINE]


Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma.
Ann Med
Xu C, Guo Y, Chen X, Liu X, Wu F, Lin S.
PMID: 41566198 [PubMed - indexed for MEDLINE]


De novo urothelial carcinoma in kidney transplant recipients: a single-center retrospective cohort study.
Int Urol Nephrol
Schmidt J, Lehnert M, Lichy I, Goranova I, Weinberger S, Jeutner J, Kurz L, Plage H, Schlomm T, Friedersdorff F, Peters R, Biernath N, Ralla B.
PMID: 41566119 [PubMed - as supplied by publisher]


Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study.
Sci Rep
Langsenlehner T, Paal K, Thurner EM, Genser S, Sternat R, Stranz B, Renner W.
PMID: 41565875 [PubMed - as supplied by publisher]


Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center.
J Robot Surg
Zhang Y, Xu P, Wen Y, Xu Y, Xu K, Li B, Zou J, Du W, Wang Y, Liu Y, Liang T, Xu A, Chen B.
PMID: 41565874 [PubMed - indexed for MEDLINE]


Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
Eur Urol Oncol
Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Ost P.
PMID: 41565552 [PubMed - as supplied by publisher]


Automated Classification of Adverse Events After Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language Models.
Urology
Sohoni N, Sohoni NS, Sutherland RA, Sundaresan VM, Smani S, Ananth P, Onofrey JA, Aneja S, Miszczyk M, Lee HJ, Olivieri JE, Leapman MS.
PMID: 41565161 [PubMed - as supplied by publisher]


European Study of Prostate Cancer Screening - 23-Year Follow-up. Reply.
N Engl J Med
Roobol MJ, de Vos II, Auvinen A.
PMID: 41564408 [PubMed - in process]


   
   Artikel 1 - 20 / 175386    Seite 1 von 8770  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1